» Articles » PMID: 36186505

Delayed Improvements in Visual Memory Task Performance Among Chronic Schizophrenia Patients After High-frequency Repetitive Transcranial Magnetic Stimulation

Overview
Specialty Psychiatry
Date 2022 Oct 3
PMID 36186505
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cognitive impairments are core characteristics of schizophrenia, but are largely resistant to current treatments. Several recent studies have shown that high-frequency repetitive transcranial magnetic stimulation (rTMS) of the left dor-solateral prefrontal cortex (DLPFC) can reduce negative symptoms and improve certain cognitive deficits in schizophrenia patients. However, results are inconsistent across studies.

Aim: To examine if high-frequency rTMS of the DLPFC can improve visual memory deficits in patients with schizophrenia.

Methods: Forty-seven chronic schizophrenia patients with severe negative symptoms on stable treatment regimens were randomly assigned to receive active rTMS to the DLPFC ( = 25) or sham stimulation ( = 22) on weekdays for four consecutive weeks. Patients performed the pattern recognition memory (PRM) task from the Cambridge Neuropsychological Test Automated Battery at baseline, at the end of rTMS treatment (week 4), and 4 wk after rTMS treatment (week 8). Clinical symptoms were also measured at these same time points using the Scale for the Assessment of Negative Symptoms (SANS) and the Positive and Negative Syndrome Scale (PANSS).

Results: There were no significant differences in PRM performance metrics, SANS total score, SANS subscores, PANSS total score, and PANSS subscores between active and sham rTMS groups at the end of the 4-wk treatment period, but PRM performance metrics (percent correct and number correct) and changes in these metrics from baseline were significantly greater in the active rTMS group at week 8 compared to the sham group (all < 0.05). Active rTMS treatment also significantly reduced SANS score at week 8 compared to sham treatment. Moreover, the improvement in visual memory was correlated with the reduction in negative symptoms at week 8. In contrast, there were no between-group differences in PANSS total score and subscale scores at either week 4 or week 8 (all > 0.05).

Conclusion: High-frequency transcranial magnetic stimulation improves visual memory and reduces negative symptoms in schizophrenia, but these effects are delayed, potentially due to the requirement for extensive neuroplastic changes within DLPFC networks.

Citing Articles

Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial.

Ye S, Guan X, Xiu M, Wu F, Huang Y Neurotherapeutics. 2024; 21(5):e00392.

PMID: 38944636 PMC: 11579878. DOI: 10.1016/j.neurot.2024.e00392.


Placebo effects of repetitive transcranial magnetic stimulation on negative symptoms and cognition in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis.

Wang M, Lu S, Hao L, Xia Y, Shi Z, Su L Front Psychiatry. 2024; 15:1377257.

PMID: 38863608 PMC: 11165700. DOI: 10.3389/fpsyt.2024.1377257.


Combining transcranial magnetic stimulation with training to improve social cognition impairment in schizophrenia: a pilot randomized controlled trial.

Vergallito A, Gramano B, La Monica K, Giuliani L, Palumbo D, Gesi C Front Psychol. 2024; 15:1308971.

PMID: 38445059 PMC: 10912559. DOI: 10.3389/fpsyg.2024.1308971.


Is it more effective for anhedonia and avolition? A systematic review and meta-analysis of non-invasive brain stimulation interventions for negative symptoms in schizophrenia.

Chen Y, Li Z, Yan C, Zou L CNS Neurosci Ther. 2024; 30(3):e14645.

PMID: 38432851 PMC: 10909625. DOI: 10.1111/cns.14645.


Editorial: Insights into structural and functional organization of the brain: evidence from neuroimaging and non-invasive brain stimulation techniques.

Tanaka M, Diano M, Battaglia S Front Psychiatry. 2023; 14:1225755.

PMID: 37377471 PMC: 10291688. DOI: 10.3389/fpsyt.2023.1225755.

References
1.
Tanaka M, Vecsei L . Editorial of Special Issue "Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry". Biomedicines. 2021; 9(5). PMC: 8148149. DOI: 10.3390/biomedicines9050517. View

2.
Spekker E, Tanaka M, Szabo A, Vecsei L . Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research. Biomedicines. 2022; 10(1). PMC: 8773152. DOI: 10.3390/biomedicines10010076. View

3.
White W . Erratum to: Why I hate the index finger. Hand (N Y). 2011; 6(2):233. PMC: 3092884. DOI: 10.1007/s11552-011-9321-0. View

4.
Wobrock T, Guse B, Cordes J, Wolwer W, Winterer G, Gaebel W . Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biol Psychiatry. 2015; 77(11):979-88. DOI: 10.1016/j.biopsych.2014.10.009. View

5.
Magavi L, Reti I, Vasa R . A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression. Int Rev Psychiatry. 2017; 29(2):79-88. DOI: 10.1080/09540261.2017.1300574. View